Using Mobile Technology-assisted Outpatient Maintenance Therapy Pediatric ALL

A Randomized Controlled Trial of Mobile Technology-assisted Outpatient Maintenance Therapy in Children With Acute Lymphoblastic Leukaemia (ALL)

NCT07278882•Institute of Hematology & Blood Diseases Hospital, China

View on ClinicalTrials.gov

Summary

To assess the efficacy of using mobile technology to improve the percentage of time wherein drug dosing is within the target range

Eligibility

Age

0 - 16 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1\) \< 16 years old at diagnosis;
•2\) having demonstrated ≥ 3 months of \> 90% compliance with using a mobile app to log in records of daily medication and weekly blood test results;
•3\) patient or legal guardian provides informed consent

Exclusion Criteria

•None

Locations (1)

Institute of Hematology & Blood Diseases Hospital

Tianjin, Tianjin Municipality, China

Key Dates

Start Date

December 1, 2025

Primary Completion Date

November 20, 2027

Completion Date

November 20, 2027

Last Updated

February 5, 2026

Enrollment

200

ESTIMATED participants

Conditions

Pediatric Acute Leukemia

Interventions

Health monitoring & reminders for a mobile-phone portal for scheduling a telemedicine clinic visit and receive periodic model-phone messages instructing follow-up blood testing and dose adjustment.

BEHAVIORAL

Contacts

Yahui Feng

CONTACT

022-23909051 fengyahui@ihcams.ac.cn

A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and Relapsed /Refractory Pediatric Acute Leukemia Patients

NCT07052994

Pediatric Acute Leukemia

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 5, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions